New Form of Insulin Can Be Inhaled Rather Than Injected


This new, quick acting insulin inhaler uses a powder (AFREZZA™) to deliver the medication.

Scientists have described a new ultra-rapid acting mealtime insulin (AFREZZA™) that is orally inhaled for absorption via the lung. Because the insulin is absorbed so rapidly, AFREZZA’s profile closely mimics the normal early insulin response seen in healthy individuals. AFREZZA is awaiting approval by the U. S. Food and Drug Administration (FDA). This presentation took place at the 239th American Chemical Society National Meeting, being held in San Francisco, California, USA March 21-25.

Continue reading… “New Form of Insulin Can Be Inhaled Rather Than Injected”